Results 251 to 260 of about 45,803 (309)

Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node Cells. [PDF]

Circulation
Ren L, Belbachir N, Zhang H, Thai PN, Huang R, Zhu W, Wu X, Xie M, Gao J, Kim HY, Liu T, Sun J, Ghazizadeh Z, Navedo MF, Wu JC.   +14 more
europepmc   +1 more source

Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders. [PDF]

Diabetes Metab Syndr Obes
Qiao Y, Zhou F, Mao T, Gao L.
europepmc   +1 more source

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity. [PDF]

Front Gastroenterol (Lausanne)
Lee JJ, Bajgain P, Lightner AL.
europepmc   +1 more source

Gαs defines the fundamental coupling mechanism of insulin secretion. [PDF]

J Diabetes Investig
Shirakawa J.
europepmc   +1 more source

GPR37 modulates body weight and insulin sensitivity in a sex-biased manner. [PDF]

PLoS One
Ahmed M, Santos MN, Abdelsayed K, Liu C, Xuseen N, Boakye PA, Owino S.   +6 more
europepmc   +1 more source

Facial nodules following filler injections after initiating compounded tirzepatide use. [PDF]

JAAD Case Rep
Luke M, Kara H, Angela M.
europepmc   +1 more source

Glucagon receptors

Cellular and Molecular Life Sciences, 2008
Glucagon is a pancreatic peptide hormone that, as a counterregulatory hormone for insulin, stimulates glucose release by the liver and maintains glucose homeostasis. First described as a glucagon binding entity functionally linked to adenylyl cyclase, the glucagon receptor is a member of the family B receptors within the G protein coupled superfamily ...
Authier, François, Desbuquois, Bernard
openaire   +5 more sources